In:
Medicina, MDPI AG, Vol. 57, No. 3 ( 2021-02-26), p. 202-
Abstract:
Leber hereditary optic neuropathy (LHON) is one of the most common inherited mitochondrial optic neuropathies, caused by mitochondrial DNA (mtDNA) mutations. Three most common mutations, namely m.11778G 〉 A, m.14484T 〉 G and m.3460G 〉 A, account for the majority of LHON cases. These mutations lead to mitochondrial respiratory chain complex I damage. Typically, LHON presents at the 15–35 years of age with male predominance. LHON is associated with severe, subacute, painless bilateral vision loss and account for one of the most common causes of legal blindness in young individuals. Spontaneous visual acuity recovery is rare and has been reported in patients harbouring m.14484T 〉 C mutation. Up to date LHON treatment is limited. Idebenone has been approved by European Medicines Agency (EMA) to treat LHON. However better understanding of disease mechanisms and ongoing treatment trials are promising and brings hope for patients. In this article we report on a patient diagnosed with LHON harbouring rare m.11253T 〉 C mutation in MT-ND4 gene, who experienced spontaneous visual recovery. In addition, we summarise clinical presentation, diagnostic features, and treatment.
Type of Medium:
Online Resource
ISSN:
1648-9144
DOI:
10.3390/medicina57030202
Language:
English
Publisher:
MDPI AG
Publication Date:
2021
detail.hit.zdb_id:
2088820-X
